Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes

Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, New York, United States
Journal of Biological Chemistry (Impact Factor: 4.57). 05/2003; 278(16):13740-6. DOI: 10.1074/jbc.M210689200
Source: PubMed


Interleukin-6 (IL-6) is one of several pro-inflammatory cytokines implicated in insulin resistance during infection, cachexia, and obesity. We recently demonstrated that IL-6 inhibits insulin signaling in hepatocytes (Senn, J. J., Klover, P. J., Nowak, I. A., and Mooney, R. A. (2002) Diabetes 51, 3391-3399). Members of the suppressors of cytokine signaling (SOCS) family associate with the insulin receptor (IR), and their ectopic expression inhibits IR signaling. Since several SOCS proteins are induced by IL-6, a working hypothesis is that IL-6-dependent insulin resistance is mediated, at least in part, by induction of SOCS protein(s) in insulin target cells. To examine the involvement of SOCS protein(s) in IL-6-dependent inhibition of insulin receptor signaling, HepG2 cells were treated with IL-6 (20 ng/ml) for periods from 1 min to 8 h. IL-6 induced SOCS-3 transcript at 30 min with a maximum effect at 1 h. SOCS-3 protein levels were also markedly elevated at 1 h. Transcript and protein levels returned to near basal levels by 2 h. SOCS-3 induction by IL-6 paralleled IL-6-dependent inhibition of IR signal transduction. Ectopically expressed SOCS-3 associated with the IR and suppressed insulin-dependent receptor autophosphorylation, insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation, association of IRS-1 with the p85 subunit of phosphatidylinositol 3-kinase, and activation of Akt. SOCS-3 was also a direct inhibitor of insulin receptor autophosphorylation in vitro. In mice exposed to IL-6 for 60-90 min, hepatic SOCS-3 expression was increased. This was associated with inhibition of hepatic insulin-dependent receptor autophosphorylation and IRS-1 tyrosine phosphorylation. These data suggest that induction of SOCS-3 in liver may be an important mechanism of IL-6-mediated insulin resistance.

Download full-text


Available from: Peter J Klover, Apr 02, 2014
  • Source
    • "eads to an increase in hepatic glucose output and hyperglycaemia ; IL - 6 has a lipolytic effect with a consequent increase of FFA levels in circulation ( Polák et al . , 2006 ) . A pro - inflammatory cytokine IL - 6 inhibits the insulin signalling cascade leading to an impairment of insulin - induced insulin receptor and IRS - 1 phosphorylation ( Senn et al . , 2003 ) . Experimental studies have confirmed that IL - 6 together with TNF - α decreased adiponectin mRNA in vitro ( Bruun et al . , 2003 ) ."
    [Show abstract] [Hide abstract]
    ABSTRACT: Adipose tissue is recognized as an active endocrine organ that produces a number of endocrine substances referred to as "adipokines" including leptin, adiponectin, adipolin, visfatin, omentin, tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), resistin, pigment epithelium-derived factor (PEDF), and progranulin (PGRN) which play an important role in the food intake regulation and significantly influence insulin sensitivity and in some cases directly affect insulin resistance in skeletal muscle, liver, and adipose tissue. The review summarizes current knowledge about adipose tissue-derived hormones and their influence on energy homeostasis regulation. The possible therapeutic potential of these adipokines in the treatment of insulin resistance, endothelial dysfunction, a pro-inflammatory response, obesity, eating disorders, progression of atherosclerosis, type 1 diabetes, and type 2 diabetes is discussed.
    Preview · Article · Jun 2015 · Prague medical report
  • Source
    • "Our findings align with those suggesting the possibility that local and systemic inflammation may be important mediators in the development of insulin resistance and type 2 diabetes in many individuals. Indeed, IL-6 may interfere with insulin signaling through the induction of proteins that bind to the insulin receptor[37]. It appears to downregulate corticosteroid-binding globulin, which may lead to increased free cortisol concentrations, insulin resistance, and other manifestations of the metabolic syndrome[38]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study examined the effect of three training intensities on abdominal obesity, insulin resistance, and C-reactive protein (CRP) levels. Forty-three young obese women (age 20–30 years; body mass index 30–40 kg/m2) underwent 12 weeks of walking programs (i.e., 5 days/week). They were randomly assigned to one of four groups: low-intensity training group [G1, 50 % of heart rate reserve (HRR), n = 11], high-intensity training group (G2, 75 % of HRR, n = 10), alternated-intensity training group (G3, 50–75 % of HRR, n = 12), and control group (G0, n = 10). They were tested before (T0) and after (T1) 12 weeks of aerobic training to determine changes in body mass, body mass index (BMI), total fat, waist circumference (WC), leptin, HOMA-IR, glucose and CRP. Body mass, BMI, total fat, and WC were significantly lower at T1 than T0 (p < 0.001) in all training groups. However, the decrease was higher in G2 than G1 and G3. Leptin levels decreased significantly in G1, G2, and G3 (p < 0.05). Only G1 showed significant decreases in CRP levels (p < 0.05). Insulin, HOMA-IR, and glucose levels decreased in the three training groups with higher decrease in G1. The low-intensity training is more effective than the high-intensity training or alternated-intensity training for improving insulin sensitivity and reducing subclinical inflammation.
    Full-text · Article · Aug 2014 · Sport Sciences for Health
  • Source
    • "On the other hand, TNFα expression after weight loss only decreased in adipose tissue, not in hepatic tissue.180 This would suggest that the liver might be a key organ for adipose tissue-derived IL6 and TNFα because continuous TNFα/IL6 exposure affects hepatic IR.189 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Non-alcoholic fatty liver disease (NAFLD) is a clinicopathological change characterized by the accumulation of triglycerides in hepatocytes and has frequently been associated with obesity, type 2 diabetes mellitus, hyperlipidemia, and insulin resistance. It is an increasingly recognized condition that has become the most common liver disorder in developed countries, affecting over one-third of the population and is associated with increased cardiovascular- and liver-related mortality. NAFLD is a spectrum of disorders, beginning as simple steatosis. In about 15% of all NAFLD cases, simple steatosis can evolve into non-alcoholic steatohepatitis, a medley of inflammation, hepatocellular injury, and fibrosis, often resulting in cirrhosis and even hepatocellular cancer. However, the molecular mechanism underlying NAFLD progression is not completely understood. Its pathogenesis has often been interpreted by the "double-hit" hypothesis. The primary insult or the "first hit" includes lipid accumulation in the liver, followed by a "second hit" in which proinflammatory mediators induce inflammation, hepatocellular injury, and fibrosis. Nowadays, a more complex model suggests that fatty acids (FAs) and their metabolites may be the true lipotoxic agents that contribute to NAFLD progression; a multiple parallel hits hypothesis has also been suggested. In NAFLD patients, insulin resistance leads to hepatic steatosis via multiple mechanisms. Despite the excess hepatic accumulation of FAs in NAFLD, it has been described that not only de novo FA synthesis is increased, but FAs are also taken up from the serum. Furthermore, a decrease in mitochondrial FA oxidation and secretion of very-low-density lipoproteins has been reported. This review discusses the molecular mechanisms that underlie the pathophysiological changes of hepatic lipid metabolism that contribute to NAFLD.
    Full-text · Article · Jul 2014 · Clinical and Experimental Gastroenterology
Show more